 patient chronic stabl exert angina period drug trial safeti standard therapi patient stabl angina placebo-control trial event trial antiangin drug support new drug applic US food drug administr person trial caus due cardiovascular event caus knowledg drug assign subject random double-blind phase placebo-control protocol withdrew cardiovascular event differ risk advers event drug placebo group subgroup analysi group calcium antagonist risk dropout placebo group disproportion number advers event studi drug conclus advers experi short-term placebo use activ treatment risk seriou cardiac event